<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<atom:link href="http://wiley-blackwell.jellycast.com/podcast/feed/7" rel="self" type="application/rss+xml" />
 <title>Dr Stuart Connolly&#039;s RE-LY Trial Podcast Interview International Journal of Stroke</title>
 <link>http://www.jellycast.com</link>
 <description>The International Journal of Stroke spoke to investigator Dr Stuart Connolly, Professor of Medicine, McMaster University</description>
 <language>en-PI</language>
 <copyright>http://creativecommons.org/licenses/by/2.0/</copyright>
 <generator>JellyCast http://www.jellycast.com</generator>
 <managingEditor>fiaria@wiley.com (wiley-blackwell)</managingEditor>
<category>Science</category>
 <pubDate>Wed, 24 Feb 2010 16:47:56 +0000</pubDate>
 <lastBuildDate>Thu, 04 Mar 2010 12:53:05 +0000</lastBuildDate>

<image>
 <url>https://wiley-blackwell.jellycast.com/files/123235932%5B1%5D_0.JPG</url>
 <title>Dr Stuart Connolly&#039;s RE-LY Trial Podcast Interview International Journal of Stroke</title>
 <link>http://www.jellycast.com</link>
<width>144</width>
<height>144</height>
 <description>The International Journal of Stroke spoke to investigator Dr Stuart Connolly, Professor of Medicine, McMaster University</description>
 </image>

 <itunes:author>International Journal of Stroke</itunes:author>
 <itunes:image href="https://wiley-blackwell.jellycast.com/files/123235932%5B1%5D.JPG" />
 <itunes:owner>
 <itunes:name>wiley-blackwell</itunes:name>
 <itunes:email>fiaria@wiley.com</itunes:email>
 </itunes:owner>
 <itunes:keywords>podcast</itunes:keywords>
 <itunes:explicit>No</itunes:explicit>
 <itunes:block>No</itunes:block>
 <itunes:subtitle>The International Journal of Stroke spoke to investigator Dr Stuart Connolly, Professor of Medicine, McMaster University</itunes:subtitle>
 <itunes:summary>The Randomized Evaluation of Long Term Anticoagulant Therapy with dabigatran was initiated to demonstrate the efficacy and safety of dabigatran in patients with non-valvular atrial fibrillation for the prevention of stroke and systemic embolism. The International Journal of Stroke spoke to investigator Dr Stuart Connolly, Professor of Medicine and Director, Division of Cardiology at McMaster University, Hamilton, Canada.</itunes:summary>
 <itunes:category text='Science' />

<item>
 <title>Dr Stuart Connolly&#039;s RE-LY Trial Podcast Interview </title>
 <link>https://wiley-blackwell.jellycast.com/node/8</link>
 <description>The Randomized Evaluation of Long Term Anticoagulant Therapy with dabigatran was initiated to demonstrate the efficacy and safety of dabigatran in patients with non-valvular atrial fibrillation for the prevention of stroke and systemic embolism. The International Journal of Stroke spoke to investigator Dr Stuart Connolly, Professor of Medicine and Director, Division of Cardiology at McMaster University, Hamilton, Canada.</description>
 <enclosure url="https://wiley-blackwell.jellycast.com/files/audio/RE-LY%20Trial%20Podcast%20interview%20International%20Journal%20of%20Stroke.mp3" length="12490210" type="audio/mpeg" />
 <pubDate>Wed, 24 Feb 2010 16:49:58 +0000</pubDate>
 <content:encoded>The Randomized Evaluation of Long Term Anticoagulant Therapy with dabigatran was initiated to demonstrate the efficacy and safety of dabigatran in patients with non-valvular atrial fibrillation for the prevention of stroke and systemic embolism. The International Journal of Stroke spoke to investigator Dr Stuart Connolly, Professor of Medicine and Director, Division of Cardiology at McMaster University, Hamilton, Canada.</content:encoded>
 <comments>https://wiley-blackwell.jellycast.com/node/8</comments>
 <dc:creator>International Journal of Stroke</dc:creator>
 <guid>https://wiley-blackwell.jellycast.com/node/8</guid>
 <itunes:subtitle>The Randomized Evaluation of Long Term Anticoagulant Therapy</itunes:subtitle>
 <itunes:summary>The Randomized Evaluation of Long Term Anticoagulant Therapy with dabigatran was initiated to demonstrate the efficacy and safety of dabigatran in patients with non-valvular atrial fibrillation for the prevention of stroke and systemic embolism. The International Journal of Stroke spoke to investigator Dr Stuart Connolly, Professor of Medicine and Director, Division of Cardiology at McMaster University, Hamilton, Canada.</itunes:summary>
 <itunes:explicit>No</itunes:explicit>
 <itunes:keywords>International Journal of Stroke Dr Stuart Connolley RE-LY Trial Interview</itunes:keywords>
 <itunes:duration>00:13:00</itunes:duration>
 <itunes:image href="https://wiley-blackwell.jellycast.com/files/123235932%5B1%5D_0.JPG" />
</item>
</channel>
</rss>
